CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,674 | $570.02 | $1.5M | 46,842 |
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,432 | $570.87 | $1.4M | 44,410 |
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,786 | $572.06 | $1.0M | 42,624 |
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,654 | $572.89 | $948K | 40,970 |
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −457 | $573.89 | $262K | 40,513 |
| 2026-04-29 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 91,288 | ||
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −239 | $565.18 | $135K | 49,774 |
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,598 | $566.14 | $905K | 48,176 |
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,489 | $567.01 | $844K | 46,687 |
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,123 | $568.07 | $1.8M | 43,564 |
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,531 | $568.93 | $871K | 42,033 |
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −926 | $569.88 | $528K | 41,107 |
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −228 | $571.08 | $130K | 40,879 |
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −366 | $571.79 | $209K | 40,513 |
| 2026-04-28 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 100,788 | ||
| 2026-04-27 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-04-27 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,716 | $565.85 | $971K | 27,160 |
| 2026-04-27 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,449 | $566.73 | $821K | 25,711 |
| 2026-04-27 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −919 | $567.81 | $522K | 24,792 |
Page 115 of 121 · 2,404 trades